Jeanne Bolger - Profile and Investment Details

Investor Profile

Jeanne Bolger is a Venture Capital, Corporate Venture Capital, Investor based in Dublin, Ireland with a diverse investment portfolio that includes companies such as AviadoBio, Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia, Direct Flow Medical, Pulmocide, NovoCure, Syntaxin, GlaxoSmithKline, Astute Medical, TopiVert, Kingdom Therapeutics Ltd, iScience Interventional, SmithKline Beecham Ireland, Padlock Therapeutics, Protagonist Therapeutics, Acclarent, BrainsgateS-Biomedic, Inspire Medical Systems, Aduro BioTech, Pronota, Mitralign, GI Dynamics, Asceneuron SA, GetWellNetwork, Inc., ImaCor, ViaCyte, ReVision Optics, Calypso Biotech, ExeVir, Arbor Surgical Technologies, Merus N.V., Binx Health, Thesan Pharmaceuticals, Genocea Biosciences, Rodin Therapeutics, Zeo, Nevro, La Lumiere, Inivata, Willow, 23andMe, Grail, Aelix Therapeutics, Optherion, Breathe Technologies, Neotract, InSound Medical, OptiScan Biomedical, Celladon, Aquinox Pharmaceuticals, Navitor Pharmaceuticals, Vedanta Biosciences, PhaseBio Pharmaceuticals, TRexBio, Intio, Life Healthcare, PowerVision, Cala Health, Neurosearch, Merus, Biocartis, CVRx, NeuroPace, Fusion Pharmaceuticals, Molecular Partners, Biolex Therapeutics, Pulmocide Limited, Sleep Solutions, Spinal Modulation, Neuron Systems, 7TM Pharma, Tengion, . Over time, Jeanne Bolger has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jeanne Bolger is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Wellness, Women Founded, Immunotherapy, Design, Life Science, Engineering, Mobile, Manufacturing, Biotechnology, Neuroscience, Clinical Trials, Research, Health Diagnostics, UK-based Startups, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Jeanne Bolger, as their portfolio suggests a familiarity and interest in this area.

Understanding Jeanne Bolger’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.